TickerFactsScreenerDevelopers

Seres Therapeutics, Inc. (MCRB) — Operating Income

Annual figures by fiscal year, from SEC filings.

2013: -$6.05M2014: -$15.08M2015: -$54.86M2016: -$92.84M2017: -$91.39M2018: -$100.28M2019: -$71.88M2020: -$88.13M2021: -$64.49M2022: -$179.91M2023: -$195.10M2024: -$121.31M2025: -$93.97M-$93.97M
2013Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$93.97M+22.5%
2024-$121.31M+37.8%
2023-$195.10M-8.4%
2022-$179.91M-179.0%
2021-$64.49M+26.8%
2020-$88.13M-22.6%
2019-$71.88M+28.3%
2018-$100.28M-9.7%
2017-$91.39M+1.6%
2016-$92.84M-69.2%
2015-$54.86M-263.7%
2014-$15.08M-149.2%
2013-$6.05M—